Part, Chapter, Paragraph
1 I, 2.Acr | CIP~Competitiveness and Innovation Framework Programme~EURIPA~
2 I, 2. 2 | quality and accessibility. Innovation is of crucial importance
3 I, 2. 2 | affordable to almost everybody. Innovation by the tourism enterprises
4 I, 2. 2 | demand. Product quality and innovation are important factors to
5 I, 2. 10. 1| soil microbiology), or for innovation in varieties and products,
6 I, 2. 10. 3| technologies~ ~The process of innovation and profusion of new information
7 I, 2. 10. 3| their competitors’ rate of innovation. Indirect effects include
8 I, 2. 10. 3| procurement and the procurement of innovation for the uptake of R&D.~Launching
9 I, 2. 10. 3| creativity and boosting innovation and productivity. These
10 I, 2. 10. 3| the Competitiveness and Innovation Framework Programme (CIP),
11 II, 5. 3. 7| barriers in implementing innovation into cancer care.~ ~Eurocan+
12 II, 5. 15. 6| public health approach to innovation”. Available at: htt m (accessed
13 III, 10. 2. 1| products and stimulating innovation. A range of substances,
14 III, 10. 2. 1| traditionally sluggish sector, innovation has become the only way
15 III, 10. 5. 3| technologies (ICT)~The process of innovation and profusion of new information
16 III, 10. 5. 3| the competitors’ rate of innovation. Indirect effects include
17 IV, 11. 3. 2| costs, it does encourage innovation (Mossialos et al, 2006).~ ~
18 IV, 11. 3. 2| pharmaceutical costs and encouraging innovation and best value, however,
19 IV, 11. 6. 1| labour costs, technological innovation and pressures from providers (
20 IV, 11. 6. 2| improved efficiency, increased innovation and more consumer-driven
21 IV, 12. 2 | barriers in implementing innovation into cancer care. In January
22 IV, 12. 4 | of Cosmetics;~Chemicals; Innovation~ENV~Environmental health
23 IV, 12. 4 | ENTR~Competitiveness and Innovation Framework Programme (CIP) (
24 IV, 12. 4 | htm); Competitiveness and Innovation Programme, Ambient Assisted
25 IV, 13. 7 | 13.7. Innovation~ ~Never before in the history
26 IV, 13. 7. 1| 13.7.1. “Innovation Cluster” initiative~ ~The
27 IV, 13. 7. 1| Instruments for supporting innovation clusters as described in
28 IV, 13. 7. 1| Section 4 of the Report on “Innovation Clusters in Europe – A statistical
29 IV, 13. 7. 1| priorities at EU level for innovation. In order to fully respond
30 IV, 13. 7. 1| cluster concept for more innovation in Europe. The combination
31 IV, 13. 7. 1| regional authorities and innovation agencies responsible for
32 IV, 13. 7. 2| edition of the European Innovation Scoreboard. The first is
33 IV, 13. 7. 2| Scoreboard. The first is that the innovation gap between the EU and the
34 IV, 13. 7. 2| running. Secondly, national innovation performances within the
35 IV, 13. 7. 2| of the state of play of innovation in the EU25 last year is
36 IV, 13. 7. 2| into five main families: innovation drivers, knowledge creation,
37 IV, 13. 7. 2| drivers, knowledge creation, innovation and entrepreneurship, applications
38 IV, 13. 7. 2| national differences between innovation leaders, innovation followers,
39 IV, 13. 7. 2| between innovation leaders, innovation followers, catching-up countries
40 IV, 13. 7. 2| order to perform well in the innovation stakes, it is necessary
41 IV, 13. 7. 2| isolation.~ ~As the EU's innovation policy becomes more sophisticated,
42 IV, 13. 7. 2| what can be done to improve innovation performance per se to ways
43 IV, 13. 7. 2| acknowledged the critical role that innovation can play for Europe to respond
44 IV, 13. 7. 4| Ethical issues concerning innovation are often very controversial
45 IV, 13. 7. 4| Addressing ethical issues of innovation is obviously very important,
